The matter came to light after The Times of India reported that Nigeria’s Drug Regulatory Authority has seized a large consignment of fake anti-malaria drugs that were made in China but stamped ‘Made in India’ to escape blame. The TOI report resulted in the Indian government lodging a protest with China.
“We are highly concerned about the case and are sending investigating officials to the Chinese provinces involved, including Guangdong,” SFDA spokesperson Yan Jiangying told a press conference.
The statement shows that SFDA headquarters is Beijing does not fully trust its provincial units to carry out monitoring and investigation into the concerned company. It came soon after the SFDA hit out against a report in a British daily saying that fake Chinese drugs are flooding the United Kingdom.
See also past posts on counterfeit medicine.